Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease Read more about Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease Synlogic Presents Additional Preclinical Data on Therapeutic Candidates SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Design (SEED) Conference Read more about Synlogic Presents Additional Preclinical Data on Therapeutic Candidates SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Design (SEED) Conference Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting Read more about Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting Synlogic Reminds Stockholders of 2021 Annual General Meeting Details Read more about Synlogic Reminds Stockholders of 2021 Annual General Meeting Details Synlogic to Present at Upcoming Virtual Banking and Industry Conference Read more about Synlogic to Present at Upcoming Virtual Banking and Industry Conference Synlogic Presents Data at Digestive Disease Week (DDW) on a Novel Approach for the Treatment of Inflammatory Bowel Disease Read more about Synlogic Presents Data at Digestive Disease Week (DDW) on a Novel Approach for the Treatment of Inflammatory Bowel Disease Synlogic Reports First Quarter Financial Results and Provides Business Update Read more about Synlogic Reports First Quarter Financial Results and Provides Business Update Synlogic Announces First Quarter 2021 Conference Call & Webcast Read more about Synlogic Announces First Quarter 2021 Conference Call & Webcast Lisa Kelly-Croswell Chair of the Compensation CommitteeMember of the Nominating & Governance Committee Lisa Kelly-Croswell Michael Heffernan Member of the Audit Committee Chair of the Nominating & Governance Committee Michael Heffernan Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease Read more about Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
Synlogic Presents Additional Preclinical Data on Therapeutic Candidates SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Design (SEED) Conference Read more about Synlogic Presents Additional Preclinical Data on Therapeutic Candidates SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting Read more about Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting
Synlogic Reminds Stockholders of 2021 Annual General Meeting Details Read more about Synlogic Reminds Stockholders of 2021 Annual General Meeting Details
Synlogic to Present at Upcoming Virtual Banking and Industry Conference Read more about Synlogic to Present at Upcoming Virtual Banking and Industry Conference
Synlogic Presents Data at Digestive Disease Week (DDW) on a Novel Approach for the Treatment of Inflammatory Bowel Disease Read more about Synlogic Presents Data at Digestive Disease Week (DDW) on a Novel Approach for the Treatment of Inflammatory Bowel Disease
Synlogic Reports First Quarter Financial Results and Provides Business Update Read more about Synlogic Reports First Quarter Financial Results and Provides Business Update
Synlogic Announces First Quarter 2021 Conference Call & Webcast Read more about Synlogic Announces First Quarter 2021 Conference Call & Webcast
Lisa Kelly-Croswell Chair of the Compensation CommitteeMember of the Nominating & Governance Committee Lisa Kelly-Croswell
Michael Heffernan Member of the Audit Committee Chair of the Nominating & Governance Committee Michael Heffernan